FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine, namely to pharmacology and cardiology, and deals with prevention of lipid exchange disorders. For this purpose, at the background of introduction of lovastatin in average therapeutic dose, additionally, intramuscularly introduced is 3-oxy-6-methyl-2-ethyl-pyridine succinate, also in dose 0.7 mg/kg daily 1 time per day during 10 days.
EFFECT: method ensures prolongation of hypolipidemic effect of lovastatin after its cancelling.
2 tbl, 4 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF NON-DRUG REDUCTION OF HYPERLIPIDEMIA | 2010 |
|
RU2454973C1 |
| METHOD FOR DRUG-FREE HYPERLIPIDAEMIA REDUCTION | 2012 |
|
RU2494747C1 |
| AGENT WITH HYPOLIPIDEMIC ACTIVITY | 2004 |
|
RU2268714C1 |
| METHOD OF MODELING NON-ALCOHOLIC STEATOHEPATITIS IN RATS | 2009 |
|
RU2394281C1 |
| METHOD FOR STEP-BY-STEP MODELING OF NONALCOHOLIC FATTY PANCREATIC DISEASE IN RATS | 2021 |
|
RU2770555C1 |
| METHOD OF TREATING PATIENTS WITH STABLE EXERTIONAL ANGINA | 2009 |
|
RU2401138C1 |
| USE OF RHODANINE DERIVATIVE 3-(2-PHENYLETHYL)-2-THIOXO-1,3 THIAZOLIDIN-4-ONE FOR NORMALIZATION OF METABOLISM, INCREASE OF NON-SPECIFIC RESISTANCE, GROWTH AND DEVELOPMENT OF ANIMALS | 2019 |
|
RU2768456C2 |
| METHOD FOR CORRECTION OF LIPOPEROXIDATION ACCOMPANYING HYPOLIPIDEMIC THERAPY OF PATIENTS WITH METABOLIC SYNDROME | 2011 |
|
RU2458687C1 |
| METHOD OF RISK EVALUATION OF METABOLIC SYNDROME IN PATIENTS WITH CHRONIC CHOLECYSTITIS | 2009 |
|
RU2403868C1 |
| METHOD OF SIMULATING MULTIPLE ORGAN PATHOLOGY IN RATS | 2011 |
|
RU2453002C1 |
